Stock Scorecard
Stock Summary for Celcuity Inc (CELC) - $10.54 as of 3/28/2025 2:36:41 PM EST
Total Score
9 out of 30
Safety Score
28 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for CELC
Positive earnings growth | |
P/E ratio less than Industry P/E Ratio | |
P/E ratio less than Sector P/E Ratio | |
P/E ratio that is half the growth rate (or less) | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Positive net income past year and 12 trailing months | |
Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for CELC
Revenue growing by at least 20% average per year over the last 5 years | |
Market Capitalization under 2 billion | |
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for CELC
Declared an ex-dividend date | |
Forward annual dividend rate greater than 2 | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Current ratio most recent quarter greater than 2 | |
Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for CELC
P/E ratio less than five-year Average P/E ratio | |
Last Price to 52 Week Low Ratio Less Than 1 | |
Total Cash Per Share > Last Day Price | |
P/S Ratio < 1 | |
P/B Ratio < 1 |
Safety Rating Criteria for CELC (28 out of 100)
Stock Price Rating (Max of 10) | 5 |
Historical Stock Price Rating (Max of 10) | 5 |
Stock Price Trend (Max of 10) | 2 |
Book Value (Max of 10) | 3 |
Book Value to Price (Max of 10) | 0 |
Analyst Buy Ratings (Max of 5) | 5 |
Analyst Strong Buy Ratings (Max of 5) | 4 |
Dividend Yield Percentage (Max of 10) | 0 |
Operating Margin (Max of 10) | 0 |
Trading Volume (Max of 10) | 4 |
Price to Earnings (Max of 10) | 0 |
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for CELC
Financial Details for CELC
Company Overview |
|
---|---|
Ticker | CELC |
Company Name | Celcuity Inc |
Country | USA |
Description | Celcuity Inc., a clinical-stage biotechnology company, discovers cancer subtypes and therapeutic options for cancer patients in the United States. The company is headquartered in Minneapolis, Minnesota. |
Sector Name | LIFE SCIENCES |
Industry Name | SERVICES-MEDICAL LABORATORIES |
Most Recent Quarter | 9/30/2024 |
Next Earnings Date | 5/13/2025 |
Stock Price History |
|
Last Day Price | 10.54 |
Price 4 Years Ago | 13.19 |
Last Day Price Updated | 3/28/2025 2:36:41 PM EST |
Last Day Volume | 118,045 |
Average Daily Volume | 260,726 |
52-Week High | 22.04 |
52-Week Low | 8.53 |
Last Price to 52 Week Low | 23.56% |
Valuation Measures |
|
Trailing PE | N/A |
Industry PE | 210.46 |
Sector PE | 40.10 |
5-Year Average PE | -7.44 |
Free Cash Flow Ratio | 1.48 |
Industry Free Cash Flow Ratio | 8.27 |
Sector Free Cash Flow Ratio | 47.05 |
Current Ratio Most Recent Quarter | 10.36 |
Total Cash Per Share | 7.11 |
Book Value Per Share Most Recent Quarter | 4.03 |
Price to Book Ratio | 2.61 |
Industry Price to Book Ratio | 2.28 |
Sector Price to Book Ratio | 21.92 |
Price to Sales Ratio Twelve Trailing Months | 0.00 |
Industry Price to Sales Ratio Twelve Trailing Months | 2.34 |
Sector Price to Sales Ratio Twelve Trailing Months | 27.78 |
Analyst Buy Ratings | 6 |
Analyst Strong Buy Ratings | 2 |
Share Statistics |
|
Total Shares Outstanding | 37,129,600 |
Market Capitalization | 391,345,984 |
Institutional Ownership | N/A |
Dividends |
|
Ex-Dividend Date | N/A |
Previous Dividend Amount | 0.0000 |
Current Dividend Amount | 0.0000 |
Total Years Dividend Increasing | N/A |
Trailing Annual Dividend Rate | 0.00 |
Trailing Annual Dividend Yield | 0.00% |
Forward Annual Dividend Rate | 0.00 |
Forward Annual Dividend Yield | 0.00% |
5-Year Dividend Payments Count | 0 |
3-Year Average Dividend Yield | 0.00% |
5-Year Average Dividend Yield | 0.00% |
1-Year Dividend Growth Rate Percentage | 0.00% |
3-Year Dividend Growth Rate Percentage | 0.00% |
5-Year Dividend Growth Rate Percentage | 0.00% |
All-Time Dividend Growth Rate Percentage | 0.00% |
Dividend Payout Ratio | N/A |
Income Statement |
|
Quarterly Earnings Growth YOY | 0.00% |
Annual Earnings Growth | -57.99% |
Reported EPS 12 Trailing Months | -2.60 |
Reported EPS Past Year | -1.91 |
Reported EPS Prior Year | -2.69 |
Net Income Twelve Trailing Months | -93,974,536 |
Net Income Past Year | -63,779,116 |
Net Income Prior Year | -40,370,040 |
Quarterly Revenue Growth YOY | 0.00% |
5-Year Revenue Growth | 0.00% |
Operating Margin Twelve Trailing Months | 0.00% |
Balance Sheet |
|
Total Cash Most Recent Quarter | 264,058,757 |
Total Cash Past Year | 180,582,748 |
Total Cash Prior Year | 168,587,511 |
Net Cash Position Most Recent Quarter | 159,218,593 |
Net Cash Position Past Year | 143,017,088 |
Long Term Debt Past Year | 37,565,660 |
Long Term Debt Prior Year | 35,755,075 |
Total Debt Most Recent Quarter | 104,840,164 |
Equity to Debt Ratio Past Year | 0.79 |
Equity to Debt Ratio Most Recent Quarter | 0.59 |
Total Stockholder Equity Past Year | 139,769,322 |
Total Stockholder Equity Prior Year | 133,771,467 |
Total Stockholder Equity Most Recent Quarter | 149,708,628 |
Free Cash Flow |
|
Free Cash Flow Twelve Trailing Months | -74,470,109 |
Free Cash Flow Per Share Twelve Trailing Months | -2.01 |
Free Cash Flow Past Year | -53,909,897 |
Free Cash Flow Prior Year | -36,166,939 |
Options |
|
Put/Call Ratio | 5.50 |
Has Options | Options Chain |
Liquidity Rating | None |
Technical Analysis |
|
Yahoo Finance Chart | Yahoo Finance Chart |
MACD | -0.19 |
MACD Signal | -0.30 |
20-Day Bollinger Lower Band | 9.46 |
20-Day Bollinger Middle Band | 11.98 |
20-Day Bollinger Upper Band | 14.49 |
Beta | 0.65 |
RSI | 47.45 |
50-Day SMA | 14.59 |
150-Day SMA | 12.31 |
200-Day SMA | 13.27 |
System |
|
Modified | 3/28/2025 8:32:59 PM EST |